Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at SOTERA HEALTH CO as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. SOTERA HEALTH CO income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. SOTERA HEALTH CO annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Michael P. Rutz
President of Sterigenics
Total Cash $698,586 Equity $997,209 Other $17,146 Total Compensation $1,712,941
Scott J. Leffler
Former CFO and Treasurer
Total Cash $305,769 Equity $1,495,817 Other $16,855 Total Compensation $1,818,441
Michael B. Petras Jr.
Chairman and CEO
Total Cash $2,180,770 Equity $14,462,702 Other $16,386 Total Compensation $16,659,858
Terrence G. Hammons Jr.
Former SVP, General Counsel and Secretary
Total Cash $835,000 Equity $897,490 Other $165,705 Total Compensation $1,898,195
Matthew J. Klaben
Former Interim SVP, General Counsel and Secretary
Total Cash $413,244 Equity $611,509 Other $13,514 Total Compensation $1,038,267
Alexander Dimitrief
SVP, General Counsel and Secretary
Total Cash $1,629,600 Equity $3,491,346 Other $1,038 Total Compensation $5,121,984
Michael F. Biehl
Interim CFO
Total Cash $415,385 Equity $0 Other $0 Total Compensation $415,385
For its 2022 fiscal year, SOTERA HEALTH CO, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Michael B. Petras Jr. CEO Pay $16,659,858 Median Employee Pay $72,660 CEO Pay Ratio 229:1
For its 2022 fiscal year, SOTERA HEALTH CO, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Ann R. Klee Total Cash $322,500
Constantine S. Mihas Total Cash $305,000
David A. Donnini Total Cash $302,500
David E. Wheadon Total Cash $310,000
James C. Neary Total Cash $320,000
Robert B. Knauss Total Cash $16,508
Ruoxi Chen Total Cash $302,500
Sean L. Cunningham Total Cash $302,500
Stephanie M. Geveda Total Cash $282,677
Vincent K. Petrella Total Cash $325,000

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.